TickerFactsScreenerDevelopers

LIGAND PHARMACEUTICALS INC (LGND) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2009: -$33.80M2010: -$27.07M2011: -$1.17M2012: $161.0K2013: $20.69M2014: $20.57M2015: $41.73M2016: $60.73M2017: $88.57M2018: $194.06M2019: -$29.34M2020: $54.59M2021: $78.80M2022: $137.85M2023: $49.58M2024: $97.05M2025: $49.36M$49.36M
2009Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$49.36M-49.1%
2024$97.05M+95.8%
2023$49.58M-64.0%
2022$137.85M+74.9%
2021$78.80M+44.4%
2020$54.59M+286.1%
2019-$29.34M-115.1%
2018$194.06M+119.1%
2017$88.57M+45.8%
2016$60.73M+45.5%
2015$41.73M+102.9%
2014$20.57M-0.6%
2013$20.69M+12750.9%
2012$161.0K+113.7%
2011-$1.17M+95.7%
2010-$27.07M+19.9%
2009-$33.80M—